Cash flow Pfizer Inc.

Equities

PFE

US7170811035

Pharmaceuticals

Market Closed - Nyse Other stock markets 04:00:02 2026-03-09 pm EDT			Pre-market 06:36:55 am
26.81 ^USD	-0.89%		26.83	+0.07%

Mar. 09	Pfizer Inc. Reports Positive Phase 2 Results for tilrekimig (PF-07275315) in Atopic Dermatitis	CI
Mar. 09	Global drugmakers rush to boost US presence as tariff threat looms	RE

9cc0ec4b18a32ffbc8285.dA6vZv7fr9RpVL2ba9e5Gc__Z77lrKvYB6GPv_bnOYQ.BEDYUL_uneAiZNvuUo2UUpqRDsqN5cXpVuDWhoWtUrBGe_UyrbScozsf_A

Published financial data: PFIZER INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	81.29B	100B	58.5B	63.63B	62.58B
Total Revenues	81.29B	100B	58.5B	63.63B	62.58B
Cost of Goods Sold, Total	30.66B	34.1B	23.99B	17.19B	15.14B
Gross Profit	50.63B	66.23B	34.51B	46.44B	47.44B
Selling General & Admin Expenses, Total	9.56B	12.2B	13.84B	14.77B	12.96B
R&D Expenses	10.52B	11.43B	10.68B	10.82B	10.44B
Amortization of Goodwill and Intangible Assets - (IS)	3.7B	3.61B	4.73B	5.29B	4.87B
Other Operating Expenses, Total	23.78B	27.24B	29.25B	30.88B	28.28B
Operating Income	26.84B	39B	5.26B	15.56B	19.16B
Interest Expense, Total	-1.29B	-1.24B	-2.21B	-3.09B	-2.67B
Interest And Investment Income	202M	565M	2.1B	817M	868M
Net Interest Expenses	-1.09B	-673M	-109M	-2.27B	-1.8B
Income (Loss) On Equity Invest.	471M	436M	505M	102M	-
Currency Exchange Gains (Loss)	-192M	-1.15B	164M	50M	-
Other Non Operating Income (Expenses)	1.88B	2.62B	1.28B	652M	1.55B
EBT, Excl. Unusual Items	27.92B	40.22B	7.09B	14.09B	18.91B
Restructuring Charges	-1.36B	-2.02B	-3.33B	-2.64B	-1.85B
Merger & Related Restructuring Charges	-	-200M	-668M	-1.4B	-773M
Gain (Loss) On Sale Of Investments	1.34B	-1.27B	1.59B	1.83B	-134M
Gain (Loss) On Sale Of Assets	99M	-	222M	-420M	-
Asset Writedown	-86M	-421M	-3.02B	-3.3B	-4.94B
In Process R&D Expenses	-	-953M	-194M	-108M	-1.61B
Insurance Settlements	-	-	-	-	-
Legal Settlements	-182M	-230M	-474M	-567M	-1.06B
Other Unusual Items	-3.42B	-394M	-157M	532M	-1.02B
EBT, Incl. Unusual Items	24.31B	34.73B	1.06B	8.02B	7.52B
Income Tax Expense	1.85B	3.33B	-1.12B	-28M	-266M
Earnings From Continuing Operations	22.46B	31.4B	2.17B	8.05B	7.79B
Earnings Of Discontinued Operations	-434M	6M	-15M	11M	25M
Net Income to Company	22.02B	31.41B	2.16B	8.06B	7.81B
Minority Interest	-45M	-35M	-39M	-31M	-41M
Net Income - (IS)	21.98B	31.37B	2.12B	8.03B	7.77B
Preferred Dividend and Other Adjustments	-	-	-	-	-
Net Income to Common Incl Extra Items	21.98B	31.37B	2.12B	8.03B	7.77B
Net Income to Common Excl. Extra Items	22.41B	31.37B	2.13B	8.02B	7.75B
Per Share Items
Net EPS - Basic	3.92	5.59	0.38	1.42	1.37
Basic EPS - Continuing Operations	4	5.59	0.38	1.42	1.36
Basic Weighted Average Shares Outstanding	5.6B	5.61B	5.64B	5.66B	5.68B
Net EPS - Diluted	3.85	5.47	0.37	1.41	1.36
Diluted EPS - Continuing Operations	3.93	5.47	0.37	1.41	1.36
Diluted Weighted Average Shares Outstanding	5.71B	5.73B	5.71B	5.7B	5.71B
Normalized Basic EPS	3.11	4.48	0.78	1.55	2.07
Normalized Diluted EPS	3.05	4.38	0.77	1.54	2.06
Dividend Per Share	1.56	1.6	1.64	1.68	1.72
Payout Ratio	39.72	28.63	436.38	118.44	125.74
American Depositary Receipts Ratio (ADR)	0.25	0.25	0.25	0.25	0.25
Supplemental Items
EBITDA	31.95B	44.02B	11.52B	22.55B	25.72B
EBITA	30.54B	42.6B	9.99B	20.84B	24.04B
EBIT	26.84B	39B	5.26B	15.56B	19.16B
EBITDAR	32.84B	45.24B	12.8B	23.73B	26.64B
Total Revenues (As Reported)	-	-	58.5B	63.63B	62.58B
Effective Tax Rate - (Ratio)	7.62	9.58	-105.39	-0.35	-3.54
Current Domestic Taxes	3.38B	2.72B	1.19B	485M	556M
Current Foreign Taxes	2.77B	4.37B	1.14B	1.59B	1.31B
Total Current Taxes	6.14B	7.09B	2.33B	2.07B	1.87B
Deferred Domestic Taxes	-4.34B	-3.58B	-2.79B	-2.2B	-1.89B
Deferred Foreign Taxes	48M	-183M	-652M	100M	-246M
Total Deferred Taxes	-4.29B	-3.76B	-3.44B	-2.1B	-2.13B
Normalized Net Income	17.4B	25.11B	4.39B	8.77B	11.78B
Interest Capitalized	108M	124M	160M	182M	166M
Non-Cash Pension Expense	-2.14B	-247M	-508M	150M	-506M
Supplemental Operating Expense Items
Advertising Expense	2B	2.8B	3.7B	3.3B	2.7B
Selling and Marketing Expenses	2B	2.8B	3.7B	3.3B	2.7B
Research And Development Expense From Footnotes	13.83B	11.43B	10.87B	10.93B	12.05B
Net Rental Expense, Total	888M	1.22B	1.28B	1.18B	924M
Imputed Operating Lease Interest Expense	240M	329M	424M	432M	311M
Imputed Operating Lease Depreciation	648M	889M	859M	745M	613M
Stock-Based Comp., Other (Total)	1.2B	891M	545M	893M	799M
Total Stock-Based Compensation	1.2B	891M	545M	893M	799M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	1.94B	416M	2.85B	1.04B	1.14B
Short Term Investments	29.12B	22.32B	9.84B	19.43B	12.45B
Trading Asset Securities, Total	4M	-	-	-	-
Total Cash And Short Term Investments	31.07B	22.73B	12.69B	20.48B	13.6B
Accounts Receivable, Total	11.48B	10.95B	11.18B	11.46B	11.87B
Other Receivables	4.27B	3.58B	3.98B	3.31B	3.97B
Total Receivables	15.74B	14.53B	15.16B	14.78B	15.84B
Inventory	9.06B	8.98B	10.19B	10.85B	10.65B
Other Current Assets, Total	3.82B	5.02B	5.3B	4.25B	2.81B
Total Current Assets	59.69B	51.26B	43.33B	50.36B	42.9B
Gross Property Plant And Equipment	32.8B	34.45B	37.91B	37.16B	38.92B
Accumulated Depreciation	-15.07B	-15.17B	-16.04B	-16.48B	-17.39B
Net Property Plant And Equipment	17.72B	19.28B	21.86B	20.68B	21.53B
Long-term Investments	21.54B	14.93B	15.38B	2.11B	1.53B
Goodwill	49.21B	51.38B	67.78B	68.53B	71.26B
Other Intangibles, Total	25.15B	43.37B	64.9B	55.41B	53.73B
Deferred Tax Assets Long-Term	1.6B	4.8B	1.8B	6.6B	7.4B
Other Long-Term Assets, Total	6.57B	12.2B	11.44B	9.71B	9.81B
Total Assets	181B	197B	227B	213B	208B
Liabilities
Accounts Payable, Total	5.58B	6.81B	6.71B	5.63B	5.24B
Accrued Expenses, Total	7.67B	8.32B	9.22B	12B	12.27B
Short-term Borrowings	605M	385M	8.1B	3.2B	154M
Current Portion of Long-Term Debt	1.64B	2.57B	2.27B	3.78B	3.02B
Current Portion of Leases	449M	620M	527M	356M	330M
Current Income Taxes Payable	1.27B	1.59B	2.35B	2.91B	3.1B
Unearned Revenue Current, Total	4.02B	2.52B	2.7B	1.51B	784M
Other Current Liabilities	21.44B	19.33B	15.92B	13.61B	12.09B
Total Current Liabilities	42.67B	42.14B	47.79B	43B	36.98B
Long-Term Debt	36.2B	33.2B	61.81B	57.8B	61.86B
Long-Term Leases	2.51B	2.6B	2.63B	2.29B	2.29B
Unearned Revenue Non Current	-	-	-	-	-
Pension & Other Post Retirement Benefits	3.72B	2.25B	2.17B	2.12B	2.04B
Deferred Tax Liability Non Current	349M	1.02B	640M	2.12B	2.4B
Other Non Current Liabilities	18.56B	20.08B	22.17B	17.58B	15.81B
Total Liabilities	104B	101B	137B	125B	121B
Preferred Stock Convertible	-	-	-	-	-
Total Preferred Equity	-	-	-	-	-
Common Stock, Total	473M	476M	478M	480M	481M
Additional Paid In Capital	90.59B	91.8B	92.63B	93.6B	94.47B
Retained Earnings	103B	126B	118B	117B	115B
Treasury Stock	-111B	-114B	-114B	-115B	-115B
Comprehensive Income and Other	-5.9B	-8.3B	-7.96B	-7.84B	-8.07B
Total Common Equity	77.2B	95.66B	89.01B	88.2B	86.48B
Minority Interest	262M	256M	274M	294M	299M
Total Equity	77.46B	95.92B	89.29B	88.5B	86.78B
Total Liabilities And Equity	181B	197B	227B	213B	208B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	5.62B	5.62B	5.65B	5.67B	5.69B
ECS Total Common Shares Outstanding	5.62B	5.62B	5.65B	5.67B	5.69B
Book Value / Share	13.74	17.03	15.77	15.56	15.21
Tangible Book Value	2.85B	916M	-43.67B	-35.74B	-38.52B
Tangible Book Value Per Share	0.51	0.16	-7.73	-6.31	-6.77
Total Debt	41.4B	39.38B	75.33B	67.42B	67.65B
Net Debt	10.32B	16.64B	62.64B	46.94B	54.05B
Debt Equivalent of Unfunded Proj. Benefit Obligation	1.73B	1.18B	561M	500M	-23M
Debt Equivalent Oper. Leases	7.1B	9.74B	10.26B	9.42B	7.39B
Minority Interest, Total (Incl. Fin. Div)	262M	256M	274M	294M	299M
Equity Method Investments, Total	16.47B	11.03B	11.64B	217M	235M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	994M	859M	1.01B	976M	907M
Inventories - Work In Process, Total	4.42B	5.52B	5.69B	6.1B	5.63B
Inventories - Finished Goods, Total	3.64B	2.6B	3.5B	3.78B	4.11B
Land - (BS)	423M	368M	353M	291M	299M
Buildings, Total	9B	8.83B	9.05B	9.04B	9.74B
Machinery, Total	16.71B	17.37B	19.66B	20.61B	21.86B
Full Time Employees	79K	83K	88K	81K	75K
Accumulated Allowance for Doubtful Accounts (Supple)	492M	449M	470M	438M	427M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	21.98B	31.37B	2.12B	8.03B	7.77B
Depreciation & Amortization - CF	1.4B	1.42B	1.52B	1.71B	1.68B
Amortization of Goodwill and Intangible Assets - (CF)	3.7B	3.61B	4.73B	5.29B	4.87B
Depreciation & Amortization, Total	5.1B	5.03B	6.26B	6.99B	6.55B
(Gain) Loss From Sale Of Asset	-	-	-	-	-
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-	-
Asset Writedown & Restructuring Costs	363M	586M	3.44B	4.26B	5.31B
Stock-Based Compensation (CF)	1.18B	872M	525M	877M	799M
Net Cash From Discontinued Operations	-343M	-	15M	-11M	-25M
Other Operating Activities, Total	-8.51B	-4.14B	-1.48B	-4.34B	-3.35B
Change In Accounts Receivable	-3.81B	261M	347M	-109M	-263M
Change In Inventories	-1.12B	592M	-1.17B	-854M	561M
Change In Accounts Payable	1.24B	1.19B	-300M	-1.02B	-469M
Change in Other Net Operating Assets	16.5B	-6.5B	-1.05B	-1.08B	-5.18B
Cash from Operations	32.58B	29.27B	8.7B	12.74B	11.7B
Capital Expenditure	-2.71B	-3.24B	-3.91B	-2.91B	-2.63B
Cash Acquisitions	-	-23B	-43.43B	-	-6.93B
Sale (Purchase) of Intangible assets	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	-19.52B	6.68B	15.24B	5.56B	8.04B
Other Investing Activities, Total	-318M	3.77B	-180M	0	165M
Cash from Investing	-22.55B	-15.78B	-32.28B	2.65B	-1.35B
Short Term Debt Issued, Total	-	3.89B	7.69B	8.91B	-
Long-Term Debt Issued, Total	997M	-	30.83B	-	9.68B
Total Debt Issued	997M	3.89B	38.52B	8.91B	9.68B
Short Term Debt Repaid, Total	-96M	-4.11B	-3M	-13.82B	-3B
Long-Term Debt Repaid, Total	-2B	-3.3B	-2.57B	-2.25B	-6.76B
Total Debt Repaid	-2.1B	-7.41B	-2.57B	-16.07B	-9.75B
Issuance of Common Stock	-	-	-	-	-
Repurchase of Common Stock	-	-2B	-	-	-
Common Dividends Paid	-8.73B	-8.98B	-9.25B	-9.51B	-9.77B
Common & Preferred Stock Dividends Paid	-	-	-	-	-
Common & Preferred Stock Dividends Paid	-8.73B	-8.98B	-9.25B	-9.51B	-9.77B
Other Financing Activities, Total	16M	-335M	-632M	-469M	-459M
Cash from Financing	-9.82B	-14.83B	26.07B	-17.14B	-10.3B
Foreign Exchange Rate Adjustments	-59M	-165M	-40M	-66M	41M
Miscellaneous Cash Flow Adjustments	-	-	-	-	-
Net Change in Cash	159M	-1.52B	2.45B	-1.81B	90M
Supplemental Items
Cash Interest Paid	1.47B	1.44B	2.22B	3.23B	2.74B
Cash Income Tax Paid (Refund)	7.43B	7.87B	3.15B	3.6B	4.69B
Levered Free Cash Flow	30.86B	24.96B	1.02B	12.3B	13.43B
Unlevered Free Cash Flow	31.66B	25.73B	2.4B	14.23B	15.1B
Change In Net Working Capital	-11.29B	1.32B	3.78B	474M	1.6B
Net Debt Issued / Repaid	-1.1B	-3.52B	35.94B	-7.16B	-74M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	10	12.87	1.55	4.42	5.68
Return on Total Capital	15.01	19.18	2.19	6.07	7.72
Return On Equity %	31.87	36.22	2.35	9.06	8.89
Return on Common Equity	31.92	36.29	2.31	9.05	8.87
Margin Analysis
Gross Profit Margin %	62.28	66.02	58.99	72.98	75.81
SG&A Margin	11.77	12.16	23.65	23.21	20.72
EBITDA Margin %	39.3	43.88	19.69	35.44	41.1
EBITA Margin %	37.58	42.46	17.08	32.76	38.41
EBIT Margin %	33.02	38.87	8.99	24.45	30.62
Income From Continuing Operations Margin %	27.63	31.3	3.71	12.65	12.44
Net Income Margin %	27.04	31.27	3.62	12.62	12.42
Net Avail. For Common Margin %	27.57	31.26	3.65	12.6	12.38
Normalized Net Income Margin	21.41	25.02	7.51	13.79	18.82
Levered Free Cash Flow Margin	37.96	24.87	1.75	19.32	21.46
Unlevered Free Cash Flow Margin	38.95	25.65	4.11	22.36	24.13
Asset Turnover
Asset Turnover	0.48	0.53	0.28	0.29	0.3
Fixed Assets Turnover	4.95	5.42	2.84	2.99	2.96
Receivables Turnover (Average Receivables)	8.38	8.95	5.29	5.53	5.36
Inventory Turnover (Average Inventory)	3.59	3.78	2.5	1.63	1.41
Short Term Liquidity
Current Ratio	1.4	1.22	0.91	1.17	1.16
Quick Ratio	1.1	0.88	0.58	0.82	0.8
Operating Cash Flow to Current Liabilities	0.76	0.69	0.18	0.3	0.32
Days Sales Outstanding (Average Receivables)	43.54	40.8	69.04	66.23	68.06
Days Outstanding Inventory (Average Inventory)	101.66	96.56	145.84	223.97	259.22
Average Days Payable Outstanding	56.77	66.45	97.92	126.52	132.79
Cash Conversion Cycle (Average Days)	88.42	70.91	116.96	163.69	194.49
Long Term Solvency
Total Debt/Equity	53.44	41.05	84.37	76.18	77.96
Total Debt / Total Capital	34.83	29.1	45.76	43.24	43.81
LT Debt/Equity	49.97	37.33	72.17	67.9	73.92
Long-Term Debt / Total Capital	32.56	26.46	39.14	38.54	41.54
Total Liabilities / Total Assets	57.32	51.36	60.58	58.53	58.31
EBIT / Interest Expense	20.79	31.5	2.38	5.03	7.17
EBITDA / Interest Expense	25.44	36.54	5.79	7.68	9.97
(EBITDA - Capex) / Interest Expense	23.34	33.93	4.03	6.74	8.99
Total Debt / EBITDA	1.26	0.87	5.89	2.84	2.54
Net Debt / EBITDA	0.31	0.37	4.89	1.98	2.03
Total Debt / (EBITDA - Capex)	1.37	0.94	8.47	3.24	2.82
Net Debt / (EBITDA - Capex)	0.34	0.4	7.04	2.25	2.25
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	95.16	23.43	-41.7	6.84	-1.65
Gross Profit, 1 Yr. Growth %	52.11	30.89	-47.9	11.19	2.16
EBITDA, 1 Yr. Growth %	123.2	37.21	-73.84	20.12	14.04
EBITA, 1 Yr. Growth %	135	38.87	-76.55	20.84	15.33
EBIT, 1 Yr. Growth %	178.19	44.54	-86.51	24.3	23.19
Earnings From Cont. Operations, 1 Yr. Growth %	236.9	39.82	-93.08	270.5	-3.28
Net Income, 1 Yr. Growth %	139.97	42.74	-93.25	279	-3.24
Normalized Net Income, 1 Yr. Growth %	168.88	42.98	-82.5	6.09	43.19
Diluted EPS Before Extra, 1 Yr. Growth %	233.05	39.19	-93.24	281.08	-3.55
Accounts Receivable, 1 Yr. Growth %	45.06	-4.59	2.05	-0.89	3.59
Inventory, 1 Yr. Growth %	12.96	-0.86	13.45	6.5	-1.82
Net Property, Plant and Equip., 1 Yr. Growth %	17.12	8.77	13.43	-5.41	4.1
Total Assets, 1 Yr. Growth %	17.67	8.67	14.86	-5.79	-2.45
Tangible Book Value, 1 Yr. Growth %	-119.43	-67.83	-4.87K	-18.17	7.79
Common Equity, 1 Yr. Growth %	22.08	23.91	-6.95	-0.91	-1.96
Cash From Operations, 1 Yr. Growth %	126.2	-10.17	-70.27	46.48	-8.16
Capital Expenditures, 1 Yr. Growth %	21.79	19.37	20.74	-25.54	-9.63
Levered Free Cash Flow, 1 Yr. Growth %	189.11	-19.34	-95.9	121.14	9.37
Unlevered Free Cash Flow, 1 Yr. Growth %	173.46	-18.95	-90.65	104.99	6.25
Dividend Per Share, 1 Yr. Growth %	2.63	2.56	2.5	2.44	2.38
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	40.97	55.2	-15.17	-20.7	2.51
Gross Profit, 2 Yr. CAGR %	23.75	41.1	-17.42	-16.8	15.49
EBITDA, 2 Yr. CAGR %	51.84	74.52	-40.09	-29.11	43.01
EBITA, 2 Yr. CAGR %	55.88	80.07	-42.93	-30.74	47.49
EBIT, 2 Yr. CAGR %	81.58	99.57	-55.85	-37.51	74.18
Earnings From Cont. Operations, 2 Yr. CAGR %	44.63	117.04	-68.89	-49.36	89.3
Net Income, 2 Yr. CAGR %	17.11	85.07	-68.95	-49.4	91.5
Normalized Net Income, 2 Yr. CAGR %	82.62	94.92	-50.06	-40.88	79.3
Diluted EPS Before Extra, 2 Yr. CAGR %	44.32	115.3	-69.32	-49.23	91.72
Accounts Receivable, 2 Yr. CAGR %	30.19	17.65	-1.32	2.31	1.32
Inventory, 2 Yr. CAGR %	13.21	5.82	6.05	9.92	2.26
Net Property, Plant and Equip., 2 Yr. CAGR %	11.48	12.87	11.08	3.58	-0.77
Total Assets, 2 Yr. CAGR %	4.06	13.08	11.72	4.02	-4.13
Tangible Book Value, 2 Yr. CAGR %	-61.3	-75	291.65	524.6	-6.08
Common Equity, 2 Yr. CAGR %	10.59	22.99	7.38	-3.98	-1.44
Cash From Operations, 2 Yr. CAGR %	60.88	42.55	-48.32	-34.01	15.99
Capital Expenditures, 2 Yr. CAGR %	15.11	20.57	20.05	-5.19	-17.97
Levered Free Cash Flow, 2 Yr. CAGR %	47.45	52.29	-81.81	-30.54	183.97
Unlevered Free Cash Flow, 2 Yr. CAGR %	44.45	48.51	-72.48	-26.39	122.64
Dividend Per Share, 2 Yr. CAGR %	4.08	2.6	2.53	2.47	2.41
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	25.81	34.86	11.99	-7.84	-14.8
Gross Profit, 3 Yr. CAGR %	16.58	26.07	1.23	-2.82	-10.91
EBITDA, 3 Yr. CAGR %	33.37	47.01	-7.29	-11.09	-16.93
EBITA, 3 Yr. CAGR %	36.19	50.21	-8.72	-12.09	-17.91
EBIT, 3 Yr. CAGR %	53.97	68.56	-18.71	-16.77	-21.65
Earnings From Cont. Operations, 3 Yr. CAGR %	79.84	43.01	-31.18	-28.96	-37.17
Net Income, 3 Yr. CAGR %	25.37	25.09	-38.61	-28.51	-37.2
Normalized Net Income, 3 Yr. CAGR %	54.32	68.81	-12.71	-20.74	-22.29
Diluted EPS Before Extra, 3 Yr. CAGR %	83.13	42.59	-32.06	-28.94	-37.12
Accounts Receivable, 3 Yr. CAGR %	12.67	17.38	12.2	-0.05	2.73
Inventory, 3 Yr. CAGR %	6.46	8.31	8.31	6.2	5.86
Net Property, Plant and Equip., 3 Yr. CAGR %	9.81	10.57	13.05	5.29	3.76
Total Assets, 3 Yr. CAGR %	4.41	5.57	13.67	5.55	1.82
Tangible Book Value, 3 Yr. CAGR %	-51.68	-63.61	43.9	132.4	247.74
Common Equity, 3 Yr. CAGR %	6.79	14.86	12.07	4.54	-3.31
Cash From Operations, 3 Yr. CAGR %	27.21	32.48	-15.47	-26.87	-26.33
Capital Expenditures, 3 Yr. CAGR %	10.97	16.51	20.63	2.38	-6.69
Levered Free Cash Flow, 3 Yr. CAGR %	188.1	20.7	-54.34	-26.48	-19.23
Unlevered Free Cash Flow, 3 Yr. CAGR %	146.54	19.25	-40.93	-23.47	-16.84
Dividend Per Share, 3 Yr. CAGR %	4.68	3.57	2.57	2.5	2.44
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	9	13.81	7.46	9.24	8.48
Gross Profit, 5 Yr. CAGR %	4.36	9.68	1.55	7.03	7.36
EBITDA, 5 Yr. CAGR %	10.21	16.08	-3.08	10.23	12.21
EBITA, 5 Yr. CAGR %	10.97	16.96	-3.74	10.64	12.84
EBIT, 5 Yr. CAGR %	13.75	21.53	-6.49	13.83	14.38
Earnings From Cont. Operations, 5 Yr. CAGR %	25.44	8.02	-10.86	-5.6	3.16
Net Income, 5 Yr. CAGR %	24.96	8.04	-28.26	-12.91	-3.23
Normalized Net Income, 5 Yr. CAGR %	13.75	22.41	-1.48	10.95	12.26
Diluted EPS Before Extra, 5 Yr. CAGR %	27.42	9.24	-10.38	-5.66	2.88
Accounts Receivable, 5 Yr. CAGR %	6.89	5.9	6.85	11.1	8.46
Inventory, 5 Yr. CAGR %	5.96	3.46	6.3	8.95	5.84
Net Property, Plant and Equip., 5 Yr. CAGR %	5.88	6.81	10.31	7.72	7.31
Total Assets, 5 Yr. CAGR %	1.12	2.8	7.28	4.95	6.18
Tangible Book Value, 5 Yr. CAGR %	-43.06	-51.29	11.59	13.45	21.32
Common Equity, 5 Yr. CAGR %	5.34	6.06	7.03	6.92	6.46
Cash From Operations, 5 Yr. CAGR %	15.01	11.74	-11.28	0.25	-4.07
Capital Expenditures, 5 Yr. CAGR %	8.26	10.59	14.51	7.29	3.38
Levered Free Cash Flow, 5 Yr. CAGR %	18.96	13.44	-4.51	-2.83	4.53
Unlevered Free Cash Flow, 5 Yr. CAGR %	18.25	12.82	2.62	-1.28	5.29
Dividend Per Share, 5 Yr. CAGR %	5.39	4.56	3.82	3.13	2.5